Indeed, when genetic instruments for HMGCR perturbation are used, or when the association between statin-use and IPF is adjusted for smoking and/or BMI, there are no associations with IPF risk [16]. The gene discussed is HMGCR; the disease is idiopathic pulmonary fibrosis.